100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Summary PERSONALITY DISORDERS NOTES $8.05
Add to cart

Summary

Summary PERSONALITY DISORDERS NOTES

 6 views  0 purchase
  • Course
  • Institution

Summary of 54 pages for the course Personality Disorders at UVT (Summary of the PDs)

Preview 4 out of 54  pages

  • April 27, 2023
  • 54
  • 2021/2022
  • Summary
avatar-seller
PERSONALITY DISORDERS
Chapter 20: Borderline Personality Disorder
CLINICAL ASPECTS
Historical Origins
 Term “border line” first used by Adolf Stern, over 70 years ago, to describe atypical and
clinically troubling groups of patients
 Term described patients who were inordinately hypersensitive, had problems with
reality testing, and who experienced negative reactions in therapy
 Stern regarded them as being between the psychoses and the neuroses
 “Borderline” reappeared two decades later when Knight (1953) used it to describe a
diagnostically uninformative state in which psychotic and neurotic features were present
in the same individual
 Others previously described such as having “pseudo-neurotic schizophrenia”
 Patients had severe impairments in their ego functions and manifested primitive
thought processes
 In the late 1960s three developments set the stage for change:
1. The psychoanalyst Otto Kernberg began to offer new clinical and theoretical insights
into “borderline personality organization”
2. Grinker and his colleagues conducted the first study of the borderline syndrome and
offered a preliminary and empirically based criterion set for the disorder
3. They identified six features for typical borderline people, including: intense affect,
impulsivity, relationship problems, brief psychotic experiences
 In the 1980s it was included in the DSM-III; however, the label “borderline” has
limitations: the name provides no descriptive information about the disorder, it is not clear
what “border” is referring to, is strongly associated with the psychoanalytic traditions
 WHO’s International Classification of Diseases terms it “emotionally unstable disorder”
Clinical Description
 DSM-IV-TR criteria for BPD (any 5 out of 9 for diagnosis):
1. Frantic efforts to avoid abandonment
2. Unstable and intense relationships
3. Identity disturbance
4. Impulsivity
5. Recurrent suicidal behavior
6. Affective instability
7. Chronic feelings of emptiness
8. Inappropriate or intense anger
9. Transient paranoid ideation or dissociation




1

, Construct is polythetic in nature and no one specific symptoms is regarded as necessary;
hence, there are 126 different ways to find 5 out of 9 criteria (heterogeneous disorder from
a clinical perspective)
 The hallmark of BPD is instability; people with BPD are “stably unstable”; mostly
manifested in: instability in emotion, interpersonal relationship, self-concept, behavior
 Around 75% of BPD patients also have paranoid ideas and/or episodes of dissociation
 BPD patients also experience higher levels of stress and stress-related psychosis
COMORBIDITY
 Axis I comorbidity is the rule rather than the exception for people with BPD
 In a study almost 70% had three or more current Axis I disorders
 Most common comorbid disorders: concurrent major depression (61%), PTSD (36%),
bipolar disorder (20%), eating disorders (17%)
 In a community sample 40% had “high-functioning BPD” (have not been hospitalized and
had no contact with a physician/mental health professional in previous year) – they were
much less likely to be suffering from comorbid Axis I conditions
Is Borderline Personality Disorder a Distinct Diagnosis?
 Large overlap between BPD and mood disorder; idea: BPD as a variant of depression –
but recent neuroimaging study has shown that BPD people show different neural activity
to certain types of emotional stimuli
 Also some overlap with PTSD; however, there is no evidence this is the case – traumatic
event is not necessary for BPD
EPIDEMIOLOGY
Prevalence
 In outpatient samples, prevalence rates of BPD are around 10%-15%; however, data from
clinical settings cannot be used to estimate the prevalence
 In community samples the lifetime prevalence ranges from 0.7% to 5.9%
 Different factors make it difficult to estimate the prevalence, but it is reasonable to assume
that in the general population, the prevalence is in the range of 1%-2%
Sex Differences
 Until recently it was commonly held that BPD was much more common in women, with
the female to male around 3:1 in psychiatric samples; but researchers now believe that this
may have been an artifact caused by sampling in clinical settings – recent studies of the
prevalence of BPD in community samples report no sex differences
 Observed prevalence seems to decrease with age – some of this decreased prevalence may
be explained by the high rate of completed suicide in BPD or the results of treatments




2

,Suicide
 Having BPD is a major risk factor for suicide – 1/3 attempt suicide
 Around 10% of patients with BPD die from suicide, mostly before becoming 40 years old
 Studies attempting to identify who is most at risk for a suicide attempt have had smixed
results, but identified some factors:
 Affective instability
 Intensity of self-reported negative mood
 Baseline major depressive disorder and poor social adjustment
 However, it is difficult to predict suicidality in BPD patients
Course and Prognosis
 People with BPD tend to be high consumers of psychiatric services, but maintaining a
clinical relationship can be challenging, because the instability of BPD patients also shows
itself in therapeutic relationships; it is not uncommon for BPD patients to terminate
treatment prematurely
 10 years follow-up study by Zanarini et al., (2010) found:
 93% showed significant reductions in symptoms and experienced a clinical remission
(they no longer meet criteria for diagnosis), lasted 2 years
 86% experienced clinical remission that lasted for 4 years or more
 Many patients clinically improved quickly with 39.3% showing clinical remission as
early as the 2-year follow-up
 4.4% died of suicide
 Recurrence of symptoms were not uncommon; around 1/3 patients who recovered lost
their recovery at some time in the 10 years
 Important to note: although they achieved a clinical remission of their symptoms,
many still had problems in psychosocial functioning; only around 50% of recovered
from BPD when recovery was defined as not meeting diagnostic criteria for BPD and
having good social and vocational functioning
 Predictors of more rapid time to clinical remission: young age, absence of history of
childhood sexual abuse, no family history of substance abuse, good recent work history,
agreeable temperament, low in neuroticism, not an anxious personality
 Expressed emotion (EE) is a measure of the family environment that has been reliably
linked to relapse and poor clinical outcome in a wide range of disorders
 In BPD patients, EE was not predictive of a more unfavorable course of illness
 BPD patients did better if their family members showed high emotional
overinvolvement (EOI) (as opposed to depression and anxiety, for example)
 Compared with dysthymic and healthy control participants, people with BPD showed
increased activation in left prefrontal cortex during EOI comments (left prefrontal
activation → positive experiences & approach motivation)




3

, ETIOLOGY AND RISK FACTORS
 Still no answer to what causes BPD; genetic and environmental factors are implicated
 Genetic and environmental factors work together, can only be separated in the abstract
Genetic Aspects
 BPD runs in families; difficult to find out how much higher the rates are, but it is
reasonable to believe that relatives have a 4-20 times higher prevalence; however, this
does not necessarily mean that it has a genetic basis, can also be environmental
 Twin studies: strong support for BPD heritable component – concordance rate in
monozygotic twins: 35%; in dizygotic twins: 7%
 Study of Distel et al. (2009) found:
 Cultural transmission does not play a significant role in development of BPD, but the
pattern of findings provided strong evidence for genetic effects in BPD
 Effects of the combined genes that are inherited are simply added together and the
sum of their effects in unison is the same as the sum of their effects when added
together (21% of variance)
 However, it also seems to be the case that nonadditive genetic effects play a role in
BPD; this is when alleles within a given locus or across different loci interact in a way
that gives rise to different effects than those that might occur simply from the presence
of the genes themselves (24% of variance)
 55% of the variance in BPD thought to be explained by unique environmental
influence
 Complex syndromes such as BPD are almost certainly polygenetic and result from
multiple genes in combination
 Different genotypes are associated with differential sensitivities to environmental stressors
Serotonin
 Serotonin (5-HT), monoamine neurotransmitter, derived from L-tryptophan, degraded by
MAO, involved in mood and appetitive behavior
 5-HT inhibits other neurotransmitter systems; low 5-HT → greater impulsivity
 Negative affect and impulsivity are central to BPD, hence serotonin is interesting
 Polymorphism = variation in the nucleotide sequence of the DNA that affects the
regulation of the gene or the functioning of its protein product
Dopamine
 Dopamine is a neurotransmitter involved in reward pathways of the brain
 Consistent with the hypothesized link between dopamine and BPD are the high rates
of substance abuse disorders in those with BPD
 Dopamine is also implicated in psychosis




4

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller izaerne. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $8.05. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

52928 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$8.05
  • (0)
Add to cart
Added